All Articles
PortfolioFunding
Phylo is building the IDE for biology, a unified environment where scientists can finally work at the speed of their thinking.
PortfolioFunding
Aurora: Developing Therapies for the Millions of Patients with Rare Diseases
Johnny began his Ph.D. evolving new Cas9 enzymes in 2012, the same year that Jennifer Doudna published her seminal paper unveiling CRISPR as a…
PerspectivePortfolio
2025: The State of AI in Healthcare
Healthcare is setting the pace for enterprise AI adoption. Long dismissed as a digital laggard that trailed years behind every major innovation wave, healthcare…
PortfolioFunding
Revolutionizing Antibody Design with AI: Why We’re Backing Chai Discovery
Chai Discovery is building foundation models for biology and drug discovery to transform how biopharma creates new therapies.
PortfolioFunding
Investing in Solace: Transforming the Way Americans Navigate Healthcare
We are excited to be leading the Series B round in Solace, a groundbreaking company that is redefining how Americans access and navigate healthcare.
FirmPortfolio
Unveiling the First Cohort of Anthology Fund-Backed AI Startups
When we launched the $100 million Anthology Fund in July with our partners at Anthropic, we set out to support cutting-edge AI startups pushing…
FundingPortfolio
Our Investment in Vilya: AI-Enabled Development of a New Class of Medicines
Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and…
PerspectivePortfolio
Key Takeaways from J.P. Morgan’s 41st Annual Healthcare Conference
For those in healthcare, JPM provides the unofficial kickoff to every new year with a chance to recap the year before and inform our…
PortfolioFunding
Empowering Behavioral Health Providers With AI: Our Investment in Eleos
Eleos is the leader in CareOps Automation for behavioral health and joins Menlo Ventures’ exciting portfolio of healthcare software and AI companies.
FundingPortfolio
Our Investment in Cartwheel: Improving Youth Mental Health
The single greatest health concern facing American kids and teens today is a crisis in mental health.
Perspective
Opportunities and Challenges of Applying Generative AI to Designing New Drugs
Drug design is both a natural fit and a unique challenge for generative AI, given large but messy datasets, time and cost of real-world…
Portfolio
Video: Building Riva With Menlo Labs
Riva Health founders Tuhin Sinha and Dag Kittlaus discuss their critical mission to revolutionize cardiovascular healthcare; their long histories with Menlo partners Greg Yap…










